CRISPR/Cas Component Separation with Coupled Ion-Exchange Columns

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for characterizing CRISPR/Cas components are limited and do not allow for simultaneous characterization of unbound Cas proteins, unbound CRISPR RNAs, and ribonucleoprotein complexes, which is crucial for ensuring the safety and efficacy of CRISPR-based therapeutics.

Innovation Solution

A method involving coupled ion exchange chromatography using cation- and anion-exchange columns, with optimized mobile phases and UV detection, allows for the separation and characterization of CRISPR/Cas components such as apo-Cas, unbound sgRNA, and RNP complexes based on their differing charges.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If current characterization methods are used, then the analysis process is simple, but simultaneous characterization of unbound Cas proteins, unbound CRISPR RNAs, and ribonucleoprotein complexes is not achieved

Engineering Contradiction:
Improvesimultaneous characterization capabilityVSAvoidchromatography system complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The system segments the analysis by using two separate chromatography columns (first column with first stationary phase, second column with second stationary phase) that can be operated independently or in combination. This allows different separation mechanisms to be applied to different components of the CRISPR/Cas mixture simultaneously, enabling comprehensive characterization without requiring a single complex column to handle all separation needs.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The dual-column system provides multi-functionality by enabling multiple characterization modes: the first column can analyze cationic components independently, the second column can analyze anionic components independently, or both columns can operate together to simultaneously characterize unbound Cas proteins, unbound CRISPR RNAs, and ribonucleoprotein complexes. This universal approach replaces the need for multiple separate analysis procedures.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Adaptability or versatility

If conventional single-column chromatography is used, then the device complexity is low, but the ability to separate and characterize all CRISPR components is insufficient

Engineering Contradiction:
Improvecomponent separation capabilityVSAvoidchromatography system complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The analysis system is segmented into two independent chromatography columns, each equipped with stationary phases having opposite charge characteristics. This segmentation allows each column to specialize in separating components with specific charge properties, thereby enhancing overall separation capability while maintaining modular simplicity in each individual column design.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The system exploits changes in the charge parameter of CRISPR components under different conditions. By using stationary phases with opposite charge characteristics, the system can selectively retain and separate components based on their charge states, enabling comprehensive separation of Cas proteins, CRISPR RNAs, and ribonucleoprotein complexes through controlled charge-based interactions.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If comprehensive quality control is implemented, then the safety and efficacy of CRISPR therapies are enhanced, but the analysis time and complexity increase

Engineering Contradiction:
Improvequality control comprehensivenessVSAvoidanalysis time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The system merges the functionality of multiple chromatography columns into a single integrated analysis platform. By coupling the first and second chromatography columns in series, the system can simultaneously perform multiple separation and characterization functions in one continuous analytical run, thereby achieving comprehensive quality control without requiring multiple separate experiments or analysis steps.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The coupled column system enables continuous analysis of CRISPR components through a single uninterrupted chromatographic run. The mobile phase flows continuously through both columns, maintaining constant separation action throughout the analysis period, which eliminates the need for intermediate sample handling or column re-equilibration steps that would otherwise increase analysis time.

Inventive Principle:
Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables comprehensive quality control of CRISPR components by allowing simultaneous characterization and monitoring of RNP formation, charge variants, and stoichiometry, enhancing the safety and efficacy of CRISPR-based therapies.

Implementation Method 1

loading a sample comprising at least one analyte onto coupled cation-exchange and anion-exchange columns

Methodology Applied
Scientific EffectIon exchange: Ion Exchange

Data Source

PatentUS20250251376A1Systems and methods for separation of crispr/CAS components
Publication Date: 2025.08.07 MRIGLOBAL
  • US20250251376A1 patent drawing
  • US20250251376A1 patent drawing
  • US20250251376A1 patent drawing

AI summary

Systems, methods, and kits for separating CRISPR/Cas components are provided. The systems, methods, and kits utilize ion exchange chromatography to separate CRISPR/Cas components based on the differing charges of CRISPR-Cas components.